MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

    C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)

    Objective: Investigate the potential of tozadenant (TOZ) to alleviate the non-motor symptoms of Parkinson's disease using multiple animal models. Background: TOZ is an oral, selective…
  • 2017 International Congress

    The Relationship between Olfactory Function and Clinical Subtypes of Parkinson’s Disease

    D.-Y. Kwon (Ansan, Republic of Korea)

    Objective: The aim of this study was to investigate the relationship between the degree of olfactory function and motor subtype of Parkinson's disease (PD).  Background:…
  • 2017 International Congress

    Olfactory dysfunction in patient of Scans Without Evidence of Dopaminergic Deficit with parkinsonian bradykinesia

    S.J. Kang, J.Y. Ahn, H.-T. Kim (Seoul, Republic of Korea)

    Objective: To investigate the differences of olfactory dysfunction in patients within SWEDDs  Background: The concept of SWEDD(scans without evidence of dopaminergic deficit) originates from the clinical…
  • 2017 International Congress

    Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease

    E. Benli, F. Ozer, N. Helvaci Yilmaz, T. Ozcan, O. Arici Duz (Ordu, Turkey)

    Objective: To investigate the relationship between urinary dysfunction (UD) and anxiety and depression in Parkinson's Disease (PD).    Background: Urinary dysfunction is one of the…
  • 2017 International Congress

    The Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale for use in Sweden

    P. Hagell, M. Nilsson, R. Chaudhuri, P. Odin (Kristianstad, Sweden)

    Objective: To translate the Non-Motor Symptoms Questionnaire (NMSQ) and the Non-Motor Symptoms Scale (NMSS) into Swedish, and test their linguistic validity and user-friendliness. Background: Non-motor…
  • 2017 International Congress

    Speech and voice response to levodopa in late-stage Parkinson’s Disease patients: report from an acute levodopa challenge

    M. Fabbri, I. Guimarães, M. Coelho, R. Cardoso, L. Guedes, M. Rosa, C. Godinho, A. Antonini, J. Ferreira (Lisbon, Portugal)

    Objective: to assess the change of speech and voice after an acute L-dopa challenge in late-stage Parkinson’s disease (LSPD). Background: PD patients are classically affected…
  • 2017 International Congress

    Subjective visual vertical in patients with early Parkinson’s disease

    H.S. Kim, H. Lee, S. Chu (Kyunggi-do, Republic of Korea)

    Objective: To identify the changes of subjective visual vertical and any correlation between SVV and cognitive/motoric dysfunctions in Parkinson's disease. Background: Dysfunction of sensory system is…
  • 2017 International Congress

    Impulsive-compulsive behaviors in patients with Parkinson´s disease in Kannur, India

    N. Svensson, S. Ovallath, R. Constantinescu (Göteborg, Sweden)

    Objective: The main aim of the project was to determine the frequency of impulsive compulsive behaviors (ICB) in patients with Parkinson´s disease (PD) in Kannur,…
  • 2017 International Congress

    Differential effects of ventral or dorsal predominant dopaminerjic denervation of striatum on development of dopamine dysregulation syndrome and punding in a rat model of parkinsonism

    E. Özkan, G. Çakmaklı, B. Elibol, E. Topçuoğlu (Ankara, Turkey)

    Objective: To model and assess the differential effects of ventral or dorsal predominant dopaminergic denervation of striatum on development of impulsive compulsive behaviors (ICB) in…
  • 2017 International Congress

    Non-motor features of p.A53T α-synuclein mutation carriers compared to sporadic Parkinson’s disease in a PPMI cohort .

    M. Stamelou, C. Koros, A. Simitsi, I. Beratis, X. Geronicola Trapali, D. Papadimitriou, N. Papagiannakis, A. Prentakis, D. Kontaxopoulou, S. Fragkiadaki, R. Antonelou, S. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: To evaluate the prevalence of non-motor symptoms in p.A53T SNCA-related PD patients as compared to sporadic PD (sPD) patients. Background: p.A53T α-synuclein (SNCA) mutation…
  • « Previous Page
  • 1
  • …
  • 1205
  • 1206
  • 1207
  • 1208
  • 1209
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Life expectancy with and without Parkinson’s disease in the general population
    • The hardest symptoms that bother patients with Parkinson's disease
    • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley